Conference abstract · 3 Oct 2016
Conference abstractPublished 3 Oct 2016
Synergy between ASH and NASH
George Washington University, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Fatty liver (hepatosteatosis) is the earliest abnormality in the pathogenesis of alcoholic steatohepatitis (ASH) and non-alcoholic steatohepatitis (NASH) and either due to metabolic risk factors associated with chronic alcohol abuse or with insulin resistance and/or metabolic syndrome in the absence of alcohol consumption. When unchecked, both ASH and NASH lead to liver fibrosis, cirrhosis, hepatocellular carcinoma (HCC) and eventual death. A number of common mechanisms contribute to the above various stages of hepatocyte injury including lipotoxicity, endotoxin release, oxidative and ER stress leading to increased pro-inflammatory cytokines that stimulate hepatic fibrogenesis and cirrhosis by activating the quiescent hepatic stellate cells (HSC) into myofibroblasts. Significantly, patients with either ASH or NASH respond favorably to early treatment modalities to reduce hepatic fat accumulation and consequently increased inflammatory signaling and activation of hepatic stellate cells. Although the pathogenic pathways associated with ASH and NASH is seemingly similar, differentiation of the molecular mechanisms of the pathogenesis of these liver diseases is critical in identifying the unique molecular signatures especially in the early diagnosis of ASH and NASH. Current clinical practice requires the invasive biopsy procedure for the conclusive diagnosis of ASH and NASH. Micro RNAs (miRNAs) are ~22 nucleotide non-coding sequences that bind to the 3'-untranslated region of target transcripts and regulate gene expression by degradation of target mRNAs or inhibition of translation. Emerging studies may prove to establish miRNAs as excellent non-invasive tools for the early diagnosis of various stages of liver diseases.
Subjects
Biochemistry & BiotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 30 Jun 2025
Ion Mobility Spectrometry-Mass Spectrometry (IMS-MS) Synergy and Advances in Analytical Power
Opinion · 19 Sep 2024
Analyzing the Synergy of Chromatography and Mass Spectrometry in Biomarker Discovery
Perspective · 31 Aug 2023
Exploring the Synergy of Biochemistry and Biotechnology: Advancing Science and Society
Mini review · 16 Aug 2023
Enhancing plant growth and yield: The synergy of bacterial partners in agriculture.
More from this journal
The newest in Journal of Glycomics & Lipidomics.
Opinion · 31 Dec 2025
Antimicrobial Properties of Bioactive Compounds Against Pathogenic Microbes
Opinion · 31 Dec 2025
Glycomics and Lipidomics Approaches to Study Membrane Structure and Function
Perspective · 31 Dec 2025
Bioactive Compounds as Modulators of Enzyme Activity and Gene Expression
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Glycomics & Lipidomics
- SubjectBiochemistry & Biotechnology
- BylineArticles whose byline prints “M Raj Lakshman”

